Haleon (HLN) Other Non-Current Assets (2021 - 2025)

Haleon (HLN) posted Other Non-Current Assets of $49.2 million for Q4 2025, down 53.24% on a QoQ basis from $105.2 million in Q4 2024, and down 53.24% year-over-year from $105.2 million in Q4 2024.

Haleon (HLN) Other Non-Current Assets (2021 - 2025) Analysis & Trends

Haleon's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $49.2 million for Q4 2025.

  • Quarterly Other Non-Current Assets fell 53.24% year-over-year to $49.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $49.2 million (down 53.24% YoY) and the FY2025 annual result came in at $48.8 million, down 53.46% from the prior year.
  • Other Non-Current Assets was $49.2 million for Q4 2025 at Haleon, down from $105.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $154.8 million in Q4 2022 and bottomed at $10.8 million in Q4 2021.
  • A 5-year average of $94.8 million and a median of $101.9 million in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 1335.69% — and 2025, when it tumbled 53.24%.
  • Haleon's Other Non-Current Assets stood at $10.8 million in 2021, then surged by 1335.69% to $154.8 million in 2022, then fell by 8.61% to $141.5 million in 2023, then fell by 25.62% to $105.2 million in 2024, then slumped by 53.24% to $49.2 million in 2025.
  • Business Quant data shows HLN's Other Non-Current Assets at $49.2 million in Q4 2025, $105.2 million in Q4 2024, and $98.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 4.40 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 49.22 Mn
Dec 31, 2024 105.25 Mn
Jun 30, 2024 98.45 Mn
Dec 31, 2023 141.49 Mn
Jun 30, 2023 141.40 Mn
Dec 31, 2022 154.83 Mn
Jun 30, 2022 56.67 Mn
Dec 31, 2021 10.78 Mn